0000899243-19-022418.txt : 20190826 0000899243-19-022418.hdr.sgml : 20190826 20190826070034 ACCESSION NUMBER: 0000899243-19-022418 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190823 FILED AS OF DATE: 20190826 DATE AS OF CHANGE: 20190826 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SASSINE ANDY CENTRAL INDEX KEY: 0001515322 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38942 FILM NUMBER: 191050470 MAIL ADDRESS: STREET 1: 82 DEVONSHIRE STREET CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arcturus Therapeutics Holdings Inc. CENTRAL INDEX KEY: 0001768224 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8589002660 MAIL ADDRESS: STREET 1: 10628 SCIENCE CENTER DRIVE STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-23 0 0001768224 Arcturus Therapeutics Holdings Inc. ARCT 0001515322 SASSINE ANDY C/O ARCTURUS THERAPEUTICS HOLDINGS INC. 10628 SCIENCE CENTER DRIVE, SUITE 250 SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer Common Stock 2019-08-23 4 P 0 10000 10.90 A 247596 D The price reported in Column 4 is a weighted average price. 1,500 shares were purchased at a price of $10.91 per share, 5,000 shares were purchased at a price of $10.94 per share and 3,500 shares were purchased at a price of $10.85 per share. Exhibit 24 - Power of Attorney /s/ Jeffrey Baumel, attorney-in-fact 2019-08-26 EX-24 2 attachment1.htm EX-24 DOCUMENT
                                                                    EXHIBIT 24

                                POWER OF ATTORNEY
        FOR SEC FILINGS ON FORMS ID, 3, 4, 5, 144, SCHEDULES 13D and 13G
                          IN RESPECT OF SECURITIES OF
                      ARCTURUS THERAPEUTICS HOLDINGS INC.

          The undersigned hereby constitutes and appoints each of Jeffrey Baumel
and Ilan Katz as his or her true and lawful attorneys - in - fact and agents,
each with full power of substitution and resubstitution for him or her in his or
her name and stead in any and all capacities, to sign and file for and on his or
her behalf, in respect of any acquisition, disposition or other change in
ownership of any Common Stock or derivative securities thereof of Arcturus
Therapeutics Holdings Inc. (the "Company"), the following:

          (i)     any Form ID to be filed with the Securities and Exchange
                  Commission (the "SEC");

          (ii)    any Initial Statement of Beneficial Ownership of Securities on
                  Form 3 to be filed with the SEC;

          (iii)   any Statement of Changes of Beneficial Ownership of Securities
                  on Form 4 to be filed with the SEC;

          (iv)    any Annual Statement of Beneficial Ownership of Securities on
                  Form 5 to be filed with the SEC;

          (v)     any Notice of Proposed Sale of Securities on Form 144 to be
                  filed with the SEC;

          (vi)    and any other forms or reports the undersigned may be required
                  to file in connection with the undersigned's ownership,
                  acquisition or disposition of securities of the Company,
                  including Schedules 13G and 13D; and

          (vii)   any and all agreements, certificates, receipts, or other
                  documents in connection therewith. The undersigned hereby
                  gives full power and authority to each attorney-in-fact to
                  seek and obtain as the undersigned's representative and on the
                  undersigned's behalf, information on transactions in the
                  Company's securities from any third party, including brokers,
                  employee benefit plan administrators and trustees, and the
                  undersigned hereby authorizes any such person to release such
                  information to the undersigned and approves and ratifies any
                  such release of information. The undersigned hereby grants
                  unto each attorney-in-fact and agent full power and authority
                  to do and perform each and every act and thing requisite and
                  necessary in connection with such matters and hereby ratifies
                  and confirms all that any such attorney-in-fact and agent or
                  substitute may do or cause to be done by virtue hereof. The
                  undersigned acknowledges that:

                  (i)   neither the Company nor any of such attorney-in-fact
                        assumes (i) any liability for the undersigned's
                        responsibility to comply with the requirement of the
                        Securities Exchange Act of 1934, as amended (the
                        "Exchange Act"), (ii) any liability of the undersigned
                        for any failure to comply with such requirements or
                        (iii) any obligation or liability of the undersigned for
                        profit disgorgement under Section 16(b) of the Exchange
                        Act; and

                  (ii)  this Power of Attorney does not relieve the undersigned
                        from responsibility for compliance with the
                        undersigned's obligations under the Exchange Act,
                        including without limitation the reporting requirements
                        under Section 16 of the Exchange Act. This Power of
                        Attorney shall remain in full force and effect until
                        revoked by the undersigned in a signed writing delivered
                        to such attorney-in-fact.


                            [Signature Page Follows]


IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney.



Date:  August 15, 2019            /s/ Andy Sassine
                                  ------------------
                                  Name: Andy Sassine